What is REGN's five-year median EV/EBITDA?

The median, or middle weekly reading, is 16.3× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Regeneron Pharmaceuticals (REGN) valuation history

Above its usual range

As of Oct 22, 2026

REGN's EV/EBITDA of 18.2x is higher than 71% of its available weekly readings from the last five years.

Share EV/EBITDA history

Shared chart range

Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/EBITDA at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

REGN year-end valuation history
Reading date	EV/EBITDA	5-year rank
Dec 29, 2025	18.2×	76%
Dec 30, 2024	17.0×	54%
Dec 25, 2023	19.8×	86%
Dec 26, 2022	11.7×	25%
Dec 27, 2021	8.8×	2%
Dec 28, 2020	16.3×	28%
Dec 30, 2019	16.0×	30%
Dec 31, 2018	17.5×	31%
Dec 25, 2017	21.0×	2%
Dec 26, 2016	31.5×	Short history

Peers on the same measure

Stock	EV/EBITDA	5-year rank
ABBVAbbVie	22.6×	88%
AMGNAmgen	19.9×	91%
GILDGilead Sciences	Unavailable	Unranked
INCYIncyte	11.7×	14%

Appears in

Health Care Stocks with Low P/E Ratios and Steady Revenue Growth Stocks Below Their 5-Year Median P/E Stocks Near Their Lowest P/E Ratios in 5 Years

Research on REGN

No published research on REGN yet. Read how valuation percentiles work.

Loading related research…

About this history

What is REGN's current EV/EBITDA?: REGN's EV/EBITDA of 18.2x is higher than 71% of its available weekly readings from the last five years.
What is REGN's five-year median EV/EBITDA?: The median, or middle weekly reading, is 16.3× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.